Creixement i Convergència Regional a Espanya i Europa

Regional policies in the supply of public goods can have a significant impact on regional disequality in Europe. In the middle or long run, equalisation of the regional supply of public and human capital will reduce regional income dispersion per head approximately be a third. The contributions of education and infrastructure investment to this amount are approximately of the same order of magnitude. Investment priorities implied by various equity and efficiency criteria are quite at variance. It doet not follow that there is allways a conflict between equity and efficiency. This is not the case in the group of regions with a low supply of public capital and un acceptable return to investment. The contribution of infrastructure police to the reduction of regional disequality in Spain during the period analysed has been very small (around 1%). The assignation of FEDER transfers has proven to be clearly a redistributive criterion. The impact of these funds has been considerable, although limited by the small volume of available resources. According to our results, FEDER has reduced dispersion of regional income in Spain, for the most optimistic scenario, around 5%, a figure which represents approximately one third of the total reduction in regional disequality during the decade of the eighties

Creixement i Convergència Regional a Espanya i Europa

Regional policies in the supply of public goods can have a significant impact on regional disequality in Europe. In the middle or long run, equalisation of the regional supply of public and human capital will reduce regional income dispersion per head approximately be a third. The contributions of education and infrastructure investment to this amount are approximately of the same order of magnitude. Investment priorities implied by various equity and efficiency criteria are quite at variance. It doet not follow that there is allways a conflict between equity and efficiency. This is not the case in the group of regions with a low supply of public capital and un acceptable return to investment. The contribution of infrastructure police to the reduction of regional disequality in Spain during the period analysed has been very small (around 1%). The assignation of FEDER transfers has proven to be clearly a redistributive criterion. The impact of these funds has been considerable, although limited by the small volume of available resources. According to our results, FEDER has reduced dispersion of regional income in Spain, for the most optimistic scenario, around 5%, a figure which represents approximately one third of the total reduction in regional disequality during the decade of the eighties

Redistributive Taxation with Endogenous Sentiments

We present a model in which an individual's sentiments towards others are determined endogenously on the basis of how they perform relative to the societal average. This, in turn, affects the individual's own behavior and hence other agents' sentiments toward her. We focus on stationary patterns of utility interdependence. To demonstrate the effects of such endogeneity, we consider an example of a production economy with redistributive taxation. There are two types of stationary equilibria: one in which all agents conform to the societal norm, into two or three groups. The main conclusion is that the tax structure, in that it affects behavior which in turn affects sentiments, plays a crucial role in determining which type of equilibrium occurs and its characteristics as well as the extent of altruism and social cohesion in society.

Impact of food waste composition on acidogenic co-fermentation with waste activated sludge

The impact of food waste (FW) composition on co-fermentation performance was studied to elucidate if adjusting FW composition can be used to drive the fermentation yield and profile, which is relevant for biorefinery applications. First, the impact of individual FW components (i.e., fruit, vegetables, pasta, rice, meat, fish, and cellulose) was assessed. Subsequently, the effect of mixing a protein-rich component and a carbohydrate-rich component was studied (i.e., fish/fruit and fish/cellulose, and meat/rice and meat/vegetable). All experiments were carried out in mesophilic batch assays using waste activated sludge (WAS) as main substrate, the same mixture ratio (70 % WAS +30 % FW on VS basis), and no pH control. Results showed that each FW component had a distinct effect on VFA yield and profile, with protein-rich components reaching the highest VFA yields; 502 and 442 mgCOD/gVS for WAS/Fish and WAS/Meat, respectively. A positive interaction on VFA yield was observed when mixing a protein-rich and a carbohydrate-rich component. This interaction was not proportional to the co-substrates proportion in the mixtures. On the other hand, the VFA profile was clearly driven by the components in the mixture, including both WAS and FW composition. Overall, these results indicate that predicting the VFA yield of WAS/FW co-fermentation is not just related to FW composition, but FW composition could be used to adjust the VFA profile to a certain extent

The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate Biopsy

Biòpsia de pròstata; Models predictius; Imatges per ressonància magnèticaProstate biopsy; Predictive models; Magnetic resonance imagingBiopsia de próstata; Modelos predictivos; Imagen de resonancia magnétic

Traffic-related air pollution, APOE ∊4 status, and neurodevelopmental outcomes among school children enrolled in the BREATHE project (Catalonia, spain)

BACKGROUND: Traffic-related air pollution is emerging as a risk factor for Alzheimer's disease (AD) and impaired brain development. Individual differences in vulnerability to air pollution may involve the e4 allele of Apolipoprotein E (APOE) gene, the primary genetic risk factor for AD. OBJECTIVE: We analyzed whether the association between traffic air pollution and neurodevelopmental outcomes is modified by APOE e4 status in children. METHODS: Data on parent-reported behavior problems (total difficulties scores, Strengths and Difficulties Questionnaire), teacher-reported attention-deficit hyperactivity disorder (ADHD) symptom scores, cognitive performance trajectories (computerized tests of inattentiveness and working memory repeated 2–4 times during January 2012–March 2013), and APOE genotypes were obtained for 1,667 children age 7–11 y attending 39 schools in or near Barcelona. Basal ganglia volume (putamen, caudate, and globus pallidum) was measured in 163 of the children by MRI (October 2012–April 2014.) Average annual outdoor polycyclic aromatic hydrocarbons (PAHs), elemental carbon (EC), and nitrogen dioxide (NO ) concentrations were estimated based on measurements at each school (two 1-wk campaigns conducted 6 months apart in 2012). RESULTS: APOE e4 allele carriers had significantly higher behavior problem scores than noncarriers, and adverse associations with PAHs and NO were stronger or limited to e4 carriers for behavior problem scores (P-interaction 0.03 and 0.04), caudate volume (P-interaction 0.04 and 0.03), and inattentiveness trajectories (P-interaction 0.15 and 0.08, respectively). Patterns of associations with the same outcomes were similar for EC. CONCLUSION: PAHs, EC, and NO were associated with higher behavior problem scores, smaller reductions in inattentiveness over time, and smaller caudate volume in APOE e4 allele carriers in our study population, and corresponding associations were weak or absent among e4 noncarriers. These findings support a potential role of APOE in biological mechanisms that may contribute to associations between air pollution and neurobehavioral outcomes in children

Review article: The need for more efficient and patient-oriented drug development pathways in NASH—setting the scene for platform trials

Drug development; Non-alcoholic steatohepatitis; Study designsDesenvolupament de fàrmacs; Esteatohepatitis no alcohòlica; Dissenys d'estudiDesarrollo de fármacos; Esteatohepatitis no alcohólica; Diseños de estudioBackground and Aims Non-alcoholic steatohepatitis (NASH) constitutes a significant unmet medical need with a burgeoning field of clinical research and drug development. Platform trials (PT) might help accelerate drug development while lowering overall costs and creating a more patient-centric environment. This review provides a comprehensive and nuanced assessment of the NASH clinical development landscape. Methods Narrative review and expert opinion with insight gained during the EU Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) project. Results Although NASH represents an opportunity to use adaptive trial designs, including master protocols for PT, there are barriers that might be encountered owing to distinct and sometimes opposing priorities held by these stakeholders and potential ways to overcome them. The following aspects are critical for the feasibility of a future PT in NASH: readiness of the drug pipeline, mainly from large drug companies, while there is not yet an FDA/EMA-approved treatment; the most suitable design (trial Phase and type of population, e.g., Phase 2b for non-cirrhotic NASH patients); the operational requirements such as the scope of the clinical network, the use of concurrent versus non-concurrent control arms, or the re-allocation of participants upon trial adaptations; the methodological appraisal (i.e. Bayesian vs. frequentist approach); patients' needs and patient-centred outcomes; main regulatory considerations and the funding and sustainability scenarios. Conclusions PT represent a promising avenue in NASH but there are a number of conundrums that need addressing. It is likely that before a global NASH PT becomes a reality, ‘proof-of-platform’ at a smaller scale needs to be provided.JMP reports having received consulting fees from Boehringer-Ingelheim, MSD and Novo Nordisk. He has received speaking fees from Gilead, Intercept, and Novo Nordisk, and travel expenses from Gilead, Rubió, Pfizer, Astellas, MSD, CUBICIN, and Novo Nordisk. He has received educational and research support from Madrigal, Gilead, Pfizer, Astellas, Accelerate, Novartis, Abbvie, ViiV, and MSD. Funds from European Commission/EFPIA IMI2 853966-2, IMI2 777377, H2020 847989, and ISCIII PI19/01898. NAdP works for Janssen. QMA is Coordinator of the EU IMI-2 LITMUS consortium, which is funded by the EU Horizon 2020 programme and EFPIA. This multistakeholder consortium includes industry partners. He reports research Grant Funding: Allergan/Tobira, AstraZeneca, Boehringer-Ingelheim, Glaxo SmithKline, Glympse Bio, Intercept, Novartis Pharma AG, Pfizer Ltd. Consultancy: 89Bio, Abbvie/Allergan, Akero, Altimentiv, Altimmune, AstraZeneca, Axcella, Blade, BMS, BNN Cardio, Boehringer-Ingelheim, Cirius, CymaBay, EcoR1, E3Bio, Eli Lilly & Company Ltd., Galmed, Genentech, Genfit SA, Gilead, Grunthal, HistoIndex, Indalo, Intercept Pharma Europe Ltd., Inventiva, IQVIA, Janssen, Johnson & Johnson, Madrigal, MedImmune, Medpace, Merck, Metacrine, NGMBio, North Sea Therapeutics, Novartis, Novo Nordisk A/S, PathAI, Pfizer Ltd., Poxel, ProSciento, Raptor Pharma, Roche, Servier, Shionogi, Terns, The Medicines Company, Viking Therapeutics. Speaker: Abbott Laboratories, Allergan/Tobira, BMS, Clinical Care Options, Falk, Fishawack, Genfit SA, Gilead, Integritas Communications, Kenes, Medscape. Royalties: Elsevier Ltd. PM works for Novartis. MSK is an employee of and a shareholder in Novo Nordisk A/S. JG has received consulting fees from Boehringer-Ingelheim, speaking fees from Echosens and travel expenses from Gilead and Abbie. Funds from ISCIII PI18/00947 and PI21/00691. JRE has received speaking fees from Gilead. FT lab’ work has been supported by the German Research Foundation (DFG, CRC/TR 362) and research grants from Gilead, Allergan, Bristol-Myers Squibb and Inventiva. VR consults for and Intercept, Novo Nordisk, Galmed, Poxel, NGM, Madrigal, Enyo, Sagimet, 89 Bio, Prosciento, Terns, and Theratechnologies, and received grants from Intercept and Gilead